Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Bone density abnormal? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Bone density abnormal have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.0% of all adverse event reports for LENALIDOMIDE.

16
Reports of Bone density abnormal with LENALIDOMIDE
0.0%
of all LENALIDOMIDE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Bone density abnormal From LENALIDOMIDE?

Of the 16 reports, 2 (12.5%) required hospitalization.

Is Bone density abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Bone density abnormal?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,039) DENOSUMAB (643) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (580) ROMOSOZUMAB-AQQG (454) TENOFOVIR DISOPROXIL (310) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (276) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (199) ADALIMUMAB (174) METHOTREXATE (155) TERIPARATIDE (146)

Which LENALIDOMIDE Alternatives Have Lower Bone density abnormal Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Bone density abnormal Reports All Drugs Causing Bone density abnormal LENALIDOMIDE Demographics